EMV Capital

EMV Capital is a London-based publicly traded venture capital and investment management group focused on early-stage deep tech and life sciences companies. Rather than operating as a drug developer, it invests in, manages, and helps build IP-rich portfolio companies through a proactive, capital-efficient model using balance-sheet capital, syndicates, and EIS-related investing activity. Its portfolio spans more than 70 companies across life sciences, healthcare, diagnostics, medtech, digital health, and other deep-tech sectors. For a biotech analyst, EMV Capital is best understood as a sector-focused venture platform and listed investment vehicle with exposure to multiple healthcare and life sciences assets rather than a single therapeutic pipeline.